COVID-19: combining antiviral and anti-inflammatory treatments.

Stebbing, Justin; Phelan, Anne; Griffin, Ivan; Tucker, Catherine; Oechsle, Olly; Smith, Dan; Richardson, Peter

Stebbing, Justin; Phelan, Anne; Griffin, Ivan; Tucker, Catherine; Oechsle, Olly; Smith, Dan; Richardson, Peter.

Stebbing J; Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK. Electronic address: j.stebbing@imperial.ac.uk.
Phelan A; Benevolent AI, London, UK.
Griffin I; Benevolent AI, London, UK.
Tucker C; Benevolent AI, London, UK.
Oechsle O; Benevolent AI, London, UK.
Smith D; Benevolent AI, London, UK.
Richardson P; Benevolent AI, London, UK.

Lancet Infect Dis ; 20(4): 400-402, 2020 04.

Article in English | MEDLINE | ID: covidwho-2700

Subject(s)

Antiviral Agents; Anti-Inflammatory Agents; Azetidines; Betacoronavirus; COVID-19; Coronavirus Infections/drug therapy; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; SARS-CoV-2; Sulfonamides; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google